Clinical trial
A Study for Patients With Osteoporosis
NCT00414973 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00414973 |
|---|---|
| Title | A Study for Patients With Osteoporosis |
| Official title | Comparison of Teriparatide and Calcitonin in the Treatment of Men and Postmenopausal Women With Osteoporosis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Teriparatide, Salmon Calcitonin |
| Enrollment | 364 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Dec 22, 2006 |
| Last update posted | Oct 28, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: